🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Appendiceal Adenocarcinoma

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) NCT07795749Phase 21 site📍 Orange University of California, Irvine · Tests: Paclitaxel Q2W, Paclitaxcel Q3W Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC NCT04779554Phase 22 sites📍 Lexington📍 Burlington Prakash Pandalai · Tests: Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2 Molecular Profiling for Risk Stratification in Appendiceal Cancer NCT07587268n/a1 site📍 Durate City of Hope Medical Center · Tests: DNA Methylation Profiling, m6A Epitranscriptomic Profiling Genetics of Appendix Cancer Study NCT05734430n/a1 site📍 Nashville Andreana Holowatyj, PhD, MSCI · Tests: Genetic profiling, Retrospective tissue procurement Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277NA1 site📍 Sacramento University of California, Davis · Tests: Ablative local therapy Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms NCT07693452Phase 21 site📍 Orange University of California, Irvine · Tests: Metformin The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry NCT07769346n/a1 site📍 Springfield Appendix Cancer Pseudomyxoma Peritonei Research Foundation A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis NCT07291180NA1 site📍 New Haven Yale University · Tests: Mass-based response testing (MRT) A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma NCT05947838NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Circulating tumoral DNA directed neoadjuvant therapy arm Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma NCT05472948Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Surufatinib, Sintilimab, Capecitabine Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551Phase 1, Phase 256 sites📍 Duarte📍 Orange📍 Sacramento Revolution Medicines, Inc. · Tests: Elironrasib, Daraxonrasib A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221Phase 1, Phase 220 sites📍 Los Angeles📍 Baltimore📍 Boston Verastem, Inc. · Tests: VS-7375, Cetuximab, Carboplatin + Pemetrexed + Pembrolizumab, Gemcitabine + Nab-paclitaxel, Pembrolizumab Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k TLR9 Immunotherapy for Peritoneal Carcinomatosis NCT07658196Phase 11 site📍 Providence Brown University · Tests: ACM-CpG A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma NCT06207305Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Dexamethasone, Diphenhydramine, Famotidine, Paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy